UK researchers have shared promising results of a phase 2 clinical trial of the type 2 diabetes drug exenatide in people with Parkinson's.
Atos Healthcare, one of the 2 companies that assesses people for Personal Independence Payment (PIP), has changed its name to 'Independent Assessment Services' (IAS).
Research released shows that a household in which a person has Parkinson's loses on average £16,582 per year due to higher health costs and reduced income.
A new report investigating the emotional, cognitive and mental health needs of people with neurological conditions like Parkinson's has been released.
The Prescription Charges Coalition has launched a report looking at the impact of prescription charges on working-age people with long-term conditions.
The All-Party Parliamentary Group on Parkinson's has launched an inquiry into anxiety and depression in Parkinson's and are seeking people's views.
New research, reported in the scientific journal Nature, suggests that the immune system plays an important role in the progression of Parkinson's.
We explain how the Queen's speech on 21 June 2017 may have an impact on people with Parkinson's, including its mention of mental health provision in the NHS.